GS0051: Pharmaceutical preparations and delivery devices, namely aerosolized oligonucleotide and steroid preparations contained within a delivery device for administration via respiratory airways for the treatment of respiratory, airway and pulmonary diseases, asthma and associated symptoms namely, bronchoconstriction, difficult breathing, wheezing, pulmonary vasoconstriction, allergic rhinitis, allergic bronchitis, pulmonary hypertension, pulmonary vasoconstriction, impeded or obstructed lung airways, respiratory tract allergies and inflammation, and for use in medical testing, diagnostic, preventive and therapeutic applications
Case File Event Statements
3/28/2003 - 21 years ago
8 - ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEType:ABN2
6/12/2002 - 22 years ago
7 - EXAMINERS AMENDMENT MAILEDType:CNEA
4/30/2002 - 22 years ago
6 - CORRESPONDENCE RECEIVED IN LAW OFFICEType:CRFA
5/21/2002 - 22 years ago
5 - REINSTATEDType:REIN
4/22/2002 - 22 years ago
4 - ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEType:ABN2